<http://webisa.webdatacommons.org/386041825>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/386041825>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.es> .
<http://webisa.webdatacommons.org/386041825>	<http://www.w3.org/ns/prov#value>	"Additional suitable modulating groups may include other cyclic and heterocyclic compounds and other compounds having similar steric ???bulk.??? Non-limiting examples of compounds that can be used to modify a ??-AP include N-acetylneuraminic acid, cholic acid, trans-4-cotininecarboxylic acid, 2-imino-1-imidazolidineacetic acid, (S)(???)-indoline-2-carboxylic acid, (???)menthoxyacetic acid, 2-norbor" .
<http://webisa.webdatacommons.org/prov/61568655>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/386041825> .